A new neurological entity manifesting as involuntary movements and dysarthria with possible abnormal copper metabolism

Journal of Neurology Neurosurgery and Psychiatry

Volumn 71, Issue 6, 2001, Pages 780-783

  Tagawa, A ^a   Ono, S ^a   Shibata, M ^a   Imai, T ^b   Suzuki, M ^a   Shimizu, N ^a  

^a TEIKYO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b SAKURA NATIONAL HOSPITAL   (Japan)

Author keywords

Serum ceruloplasmin; Serum copper; Urinary copper excretion; Wilson's disease

Indexed keywords

CERULOPLASMIN; COPPER;

ADULT; ARTICLE; ATHETOSIS; BASAL GANGLION; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; COPPER METABOLISM; DEMENTIA; DISEASE ASSOCIATION; DYSARTHRIA; DYSTONIA; FEMALE; HUMAN; INVOLUNTARY MOVEMENT; LIVER CIRRHOSIS; MALE; MENKES SYNDROME; MORTALITY; MYOCLONUS; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; SLURRED SPEECH; URINARY EXCRETION; WILSON DISEASE;

ADULT; AGE OF ONSET; BRAIN DISEASES, METABOLIC, INBORN; CERULOPLASMIN; COPPER; DYSARTHRIA; DYSKINESIAS; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; METAL METABOLISM, INBORN ERRORS;

EID: 0035205449     PISSN: 00223050     EISSN: None     Source Type: Journal    
DOI: 10.1136/jnnp.71.6.780     Document Type: Article

References (14)

1. Wilson SAK. Progressive lenticular degeneration: a familial nervous disease associated with cirrhosis of the liver. Brain 1912;34:295-309.
2. Menkes JH, Alter M, Steigleder GK, et al. A sex-linked recessive disorder with retardation of growth, peculiar hair, and focal cerebral and cerebellar degeneration. Pediatrics 1962;50:764-79.
3. Morita H, Ikeda S, Yamamoto K, et al. Hereditary ceruloplasmin deficiency with hemosiderosis: a clinico-pathological study of a Japanese family. Ann Neurol 1995;37:646-56.
4. Ono S, Kurisaki H. An unusual neurological disorder with abnormal copper metabolism. J Neurol 1988;235:397-9.
5. Godwin-Austen RB, Robinson A, Evans K, et al. An unusual neurological disorder of copper metabolism clinically resembling Wilson's disease but biochemically a distinct entity. J Neurol Sci 1978;39:85-98.
6. Haas RH, Chir B, Robinson A, et al. An X linked disease of the nervous system with disordered copper metabolism and features differing from Menkes disease. Neurology 1981;31: 852-9.
7. Willvonseder R, Golstein NP, McCall JT, et al. A hereditary disorder with dementia, spastic dysarthria, vertical eye movement paresis, gait disturbance, splenomegaly, and abnormal copper metabilism. Neurology 1973;23:1039-49.
8. Waggoner DJ, Bartnikas TB, Gitlin JD. The role of copper in neurodegenerative disease. Neurobiol Dis 1999;6:221-30.
9. Roh JK, Lee TG, Wie BA, et al. Initial and follow up brain MRI findings and correlation with the clinical course in Wilson's disease. Neurology 1994;44:1064-8.
10. Marecek Z, Nevsimalova S. Biochemical and clinical changes in Wilson's disease heterozygotes. J Inherit Metab Dis 1984;7:41-5.
11. Maier-Dobersberger T, Mannhalter C, Rack S. Diagnosis of Wilson's disease in an asymptomatic sibling by DNA linkage analysis. Gastroenterology 1995;109:2015-8.
12. Cemirkiran M, Jankovic J, Lewis RA, et al. Neurologic presentation of Wilson disease without Kayser-Fleischer rings. Neurology 1996;46:1040-3.
13. Ross ME, Jakobson IM, Dienstag JL, et al. Late onset Wilson's disease with neurological involvement in the absence of Kayser-Fleishcer rings. Ann Neurol 1985;17:411-3.
14. Yuce A, Kocak N, Ozen H, et al. Wilson's disease patients with normal ceruloplasmin levels. Turk J Pediatr 1999;41: 99-102.